Predicting cerebral infarction in patients with atrial fibrillation using machine learning: The Fushimi AF registry

1. Wolf, PA, Abbott, RD, Kannel, WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983–988.
Google Scholar | Crossref | Medline | ISI2. Gage, BF, Waterman, AD, Shannon, W, et al. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 2001; 285: 2864–2870.
Google Scholar | Crossref | Medline | ISI3. Lip, GY, Nieuwlaat, R, Pisters, R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263–273.
Google Scholar | Crossref | Medline | ISI4. Alkhouli, M, Friedman, PA. Ischemic stroke risk in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2019; 74: 3050–3065.
Google Scholar | Crossref | Medline5. Yaghi, S, Kamel, H. Stratifying stroke risk in atrial fibrillation. Beyond clinical risk scores. Stroke 2017; 48: 2665–2670.
Google Scholar | Crossref | Medline6. Ogawa, H, An, Y, Ikeda, S, et al.; on behalf of the Fushimi AF Registry Investigators . Progression from paroxysmal to sustained atrial fibrillation is associated with increased adverse events. Stroke 2018; 49: 2301–2308.
Google Scholar | Crossref | Medline7. Nishi, H, Oishi, N, Ishii, A, et al. Predicting clinical outcomes of large vessel occlusion before mechanical thrombectomy using machine learning. Stroke 2019; 50: 2379–2388.
Google Scholar | Crossref | Medline8. Lee, SI, Celik, S, Logsdon, BA, et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 2018; 9: 42.
Google Scholar | Crossref | Medline9. Akao, M, Chun, YH, Wada, H, Fushimi AF Registry Investigators et al. Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF registry. J Cardiol 2013; 61: 260–266.
Google Scholar | Crossref | Medline10. Aloisio, MK, Swanson, AS, Micali, N, et al. Analysis of partially observed clustered data using generalized estimating equations and multiple imputation. Stata J 2014; 14: 863–883.
Google Scholar | SAGE Journals11. Steyerberg, EW, Vergouwe, Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J 2014; 35: 1925–1931.
Google Scholar | Crossref | Medline | ISI12. Breiman, L. Random forests. Machine Learning 2001; 45: 5–32.
Google Scholar | Crossref | ISI13. Prokhorenkova L, Gusev G, Vorobev A, et al. CatBoost: unbiased boosting with categorical features. ArXiv 1706.09516.
Google Scholar14. Aakre, CA, McLeod, CJ, Cha, SS, et al. Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation. Stroke 2014; 45: 426–431.
Google Scholar | Crossref | Medline15. Fuster, V, Ryden, LE, Cannom, DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Eur Heart J 2006; 27: 1979–2030.
Google Scholar | Crossref | Medline | ISI16. Hanley, JA, McNeil, BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–843.
Google Scholar | Crossref | Medline | ISI17. Piccini, JP, Stevens, SR, Chang, Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation) and ATRIA (AnTicoagulation and risk factors in Atrial Fibrillation) Study Cohorts. Circulation 2013; 127: 224–232.
Google Scholar | Crossref | Medline | ISI18. Van den Ham, HA, Olaf, HK, Singer, DE, et al. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation. Results from a national primary care database. J Am Coll Cardiol 2015; 66: 1851–1859.
Google Scholar | Crossref | Medline | ISI19. Olesen, JB, Lip, GYH, Hansen, ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; 342: d124.
Google Scholar | Crossref | Medline20. Singer, DE, Chang, Y, Borowsky, LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc 2013; 2: e000250.
Google Scholar | Crossref | Medline21. Chao, TF, Lip, GYH, Liu, CJ, et al. Validation of a modified CHA2DS2-VASc score for stroke risk stratification in asian patients with atrial fibrillation: a nationwide cohort study. Stroke 2016; 47: 2462–2469.
Google Scholar | Crossref | Medline22. Hijazi, Z, Lindback, J, Alexander, JH, et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J 2016; 37: 1582–1590.
Google Scholar | Crossref | Medline | ISI23. D'Agostino, RB, Pencina, MJ, Massaro, JM, et al. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart 2013; 8: 11–23.
Google Scholar | Crossref | Medline24. Li, X, Li, H, Du, X, et al. Integrated machine learning approaches for predicting ischemic stroke and thromboembolism in atrial fibrillation. AMIA Annu Symp Proc 2017; 10: 799–807.
Google Scholar25. Han, L, Askari, M, Altman, RB, et al. Atrial fibrillation burden signature and near-term prediction of stroke. A machine learning analysis. Circ Cardiovasc Qual Outcomes 2019; 12: e005595.
Google Scholar | Crossref | Medline26. Inohara, T, Shrader, P, Pieper, K, et al. Association of atrial fibrillation clinical phenotypes with treatment patterns and outcomes. A multicenter registry study. JAMA Cardiol 2018; 3: 54–63.
Google Scholar | Crossref | Medline27. Go, AS, Fang, MC, Udaltsova, N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119: 1363–1369.
Google Scholar | Crossref | Medline | ISI28. Wada, Y, Mizushige, K, Ohmori, K, et al. Prevention of cerebral thromboembolism by low-dose anticoagulant therapy in atrial fibrillation with mitral regurgitation. J Cardiovasc Pharmacol 2001; 37: 422–426.
Google Scholar | Crossref | Medline29. Bisson, A, Bernard, A, Bodin, A, et al. Stroke and thromboembolism in patients with atrial fibrillation and mitral regurgitation. Circ Arrhythm Electrophysiol 2019; 12: e006990.
Google Scholar | Crossref | Medline30. Hamatani, Y, Ogawa, H, Uozumi, R, et al. Low body weight is associated with the incidence of stroke in atrial fibrillation patients – insight from the Fushimi AF registry. Circ J 2015; 79: 1009–1017.
Google Scholar | Crossref | Medline31. Lee, S-R, Choi, E-K, Jung, J-H, et al. Body mass index and clinical outcomes in Asian patients with atrial fibrillation receiving oral anticoagulation. Stroke 2021; 52: 521–530.
Google Scholar | Crossref | Medline32. Aguilar, M, Lart, R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2005; 19: CD001925.
Google Scholar33. Corley, SD, Epstein, AE, DiMarco, JP, et al.; AFFIRM Investigators . The AFFIRM investigators. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 2004; 109: 1509–1513.
Google Scholar | Crossref | Medline | ISI34. Tezuka, Y, Iguchi, M, Hamatani, Y, et al. Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: the Fushimi AF registry. Eur Heart J Qual Care Clin Outcomes 2020; 6: 273–283.
Google Scholar | Crossref | Medline35. Hamatani, Y, Ogawa, H, Takabayashi, K, et al. Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep 2016; 6: 31042.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif